As of 2024-12-11, the Fair Value of Regenxbio Inc (RGNX) is -24.10 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.76 USD, the upside of Regenxbio Inc is -346.90%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -94.70 | -111.30 | 127.80 | -280.30 | -263.49 | -124.40 |
| YoY growth | -194.79% | -17.53% | 214.82% | -319.33% | 6.00% | -62.17% |
| Market Cap (mil) | 483.61 |
| P/E | |
| Forward P/E |
| EPS | -4.82 |
| Avg earnings growth rate | -62.17% |
| TTM earnings | -238.81 |